P&G Ventures highlights ‘second skin’ microbiome solution in virtual innovation challenge

Join executive leaders at the Conversational AI &amp Intelligent AI Assistants Summit, presented by Five9. Watch now!

P&ampG Ventures, the internal startup studio of Procter &amp Gamble, named “second skin” startup Nanospun Technologies as the winner of its Virtual Innovation Challenge today.

The business was one of 4 finalists in a competitors overseen by P&ampG Ventures, which highlights startups in sectors exactly where the customer items giant does not however compete. P&ampG Ventures mentioned they think the finalists all have the power to revolutionize the way customers live, age, and care for themselves and their households.

Ohad Bendror, CEO of NanoSpun Technologies, made the pitch for his business. The Israel-based business develops “live active skincare products” based on a bioprinting technologies, and its items are made out of live cells and organisms. The business says it is harnessing the energy of biology and industrial tech to make a skincare face mask. The face mask industry is estimated to be $1.4 billion by 2024, according to industry researcher KBV Research.

NanoSpun says its mask offers microbiome protection, enhancing the skin as a essential barrier in between ourselves and the atmosphere. The skin microbiome is the fantastic bacteria on our skin, and it releases healthful components such as vitamins, acids, and proteins. A healthful microbiome increases hydration, elasticity, and anti-aging, Bendror mentioned in a presentation. It also decreases wrinkles, ultraviolet harm, and sensitivity.

Image Credit: NanoSpun

To assistance that microbiome, NanoSpun is developing “second skin” items which are live, active probiotics that release fresh, active compounds for the skin. “It boosts skin health and beauty,” Bendror mentioned.

The business will sell the mask below its personal brand and license it to other folks. It is finishing skin model testing and will start out promoting the solution next year, Bendror mentioned.

Virtual Innovation Challenge finalists

The other Virtual Innovation Challenge finalists incorporated Wellesley Pharmaceuticals, headed by CEO David Dill. His business developed Nocturol, a pill developed to provide as a great deal as eight hours of relief for these who want to make frequent bathroom trips overnight. The pill is awaiting the final results of clinical trials.

Another candidate was Ready, Set, Food. CEO Daniel Zakowski mentioned the business desires to finish meals allergies. It is creating an early meals allergen technique that gently introduces a child to peanut, egg, and milk in the type of a every day supplement. Designed by a group of physicians and parents, the aim is to make early allergen introduction as protected and uncomplicated as attainable for households as they strive to lower allergen danger in children.

Juliana Carvalho, cofounder of One Skin, mentioned her business is creating a topical supplement developed to extend your skin’s lifespan on a molecular level, purporting to strengthen skin well being and strength and give customers more youthful-hunting skin for longer. The solution is vegan and cruelty-no cost, and created by a group of female PhDs.

Originally appeared on: TheSpuzz